Published in Biotechniques on October 01, 1990
Biological implications of polydimethylsiloxane-based microfluidic cell culture. Lab Chip (2009) 2.59
Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol in vitro: new data and a brief review. Environ Health Perspect (2007) 1.95
Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function. Mol Cell Biol (2001) 1.57
Genetic variability in MCF-7 sublines: evidence of rapid genomic and RNA expression profile modifications. BMC Cancer (2003) 1.34
The IGF pathway regulates ERα through a S6K1-dependent mechanism in breast cancer cells. Mol Endocrinol (2011) 1.27
Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals. Environ Health Perspect (2004) 1.06
Regulation of estrogen receptor α N-terminus conformation and function by peptidyl prolyl isomerase Pin1. Mol Cell Biol (2011) 1.00
Xenoestrogenic activity in blood of European and Inuit populations. Environ Health (2006) 0.92
Tamoxifen resistance and epigenetic modifications in breast cancer cell lines. Curr Med Chem (2007) 0.89
Degradation of estrogens by Rhodococcus zopfii and Rhodococcus equi isolates from activated sludge in wastewater treatment plants. Appl Environ Microbiol (2004) 0.88
Dietary estrogens stimulate human breast cells to enter the cell cycle. Environ Health Perspect (1997) 0.86
Estrogenic potency of bisphenol S, polyethersulfone and their metabolites generated by the rat liver S9 fractions on a MVLN cell using a luciferase reporter gene assay. Reprod Biol Endocrinol (2014) 0.78
Naringenin: a partial agonist on estrogen receptor in T47D-KBluc breast cancer cells. Int J Clin Exp Med (2013) 0.76
Tetrahydro-iso-alpha Acids Antagonize Estrogen Receptor Alpha Activity in MCF-7 Breast Cancer Cells. Int J Endocrinol (2016) 0.75
Detection of organic compounds with whole-cell bioluminescent bioassays. Adv Biochem Eng Biotechnol (2014) 0.75
Use of viral promoters in mammalian cell-based bioassays: How reliable? J Transl Med (2004) 0.75
Screening for potential endocrine disruptors in fish: evidence from structural alerts and in vitro and in vivo toxicological assays. Environ Sci Eur (2016) 0.75
The in vitro estrogenic activities of polyfluorinated iodine alkanes. Environ Health Perspect (2011) 0.75
Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol (1996) 5.71
The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol Cell Biol (1994) 3.16
Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells. Gene Ther (2000) 2.95
Characterization of monoclonal antibodies and polyclonal immune sera directed against human cytomegalovirus virion proteins. Virology (1984) 2.48
Mapping EBNA-1 domains involved in binding to metaphase chromosomes. J Virol (1999) 2.40
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology (2010) 2.30
Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes. J Virol (2001) 2.25
Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci U S A (1994) 2.21
Homo-FRET microscopy in living cells to measure monomer-dimer transition of GFP-tagged proteins. Biophys J (2001) 2.07
Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay. J Clin Microbiol (2001) 1.97
Monoclonal antibodies against respiratory syncytial virus and their use for rapid detection of virus in nasopharyngeal secretions. J Clin Microbiol (1985) 1.96
Quantification of human cytomegalovirus DNA by real-time PCR. J Clin Microbiol (2001) 1.82
Isolation of a human pararotavirus. Virology (1983) 1.73
In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene. Cancer Res (2000) 1.73
Quantification of enterovirus RNA in sludge samples using single tube real-time RT-PCR. Biotechniques (2000) 1.67
Identification of Epstein-Barr virus sequences that encode a nuclear antigen expressed in latently infected lymphocytes. Proc Natl Acad Sci U S A (1984) 1.66
A ubiquitous mammalian expression vector, pHMG, based on a housekeeping gene promoter. Nucleic Acids Res (1989) 1.65
Mapping of the gene coding for Epstein-Barr virus-determined nuclear antigen EBNA3 and its transient overexpression in a human cell line by using an adenovirus expression vector. J Virol (1987) 1.61
Nucleotide sequence of SHV-2 beta-lactamase gene. Antimicrob Agents Chemother (1990) 1.61
Quantitative analysis of human herpesvirus 8 viral load using a real-time PCR assay. J Clin Microbiol (2000) 1.60
Transcriptional interference between the EBV transcription factors EB1 and R: both DNA-binding and activation domains of EB1 are required. Nucleic Acids Res (1991) 1.53
In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted. J Virol (1998) 1.45
Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells. J Virol (2000) 1.40
Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset. J Virol (1999) 1.40
Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease. J Virol (2002) 1.39
[Preimplantation diagnosis of delta F508 mutation of mucoviscidosis in transgenic mice]. Presse Med (1995) 1.38
Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids. Cancer Lett (1998) 1.31
Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression. Gene Ther (1997) 1.31
Fiberless recombinant adenoviruses: virus maturation and infectivity in the absence of fiber. J Virol (1999) 1.28
Trafficking of the androgen receptor in living cells with fused green fluorescent protein-androgen receptor. Mol Cell Endocrinol (1997) 1.27
A one-year virological survey of acute intussusception in childhood. J Med Virol (1982) 1.24
Phylogenetic analyses indicate an atypical nurse-to-patient transmission of human immunodeficiency virus type 1. J Virol (2000) 1.19
An efficient procedure to select and recover recombinant adenovirus vectors. Gene Ther (1995) 1.19
The DNA-binding domain of two bZIP transcription factors, the Epstein-Barr virus switch gene product EB1 and Jun, is a bipartite nuclear targeting sequence. J Virol (1993) 1.18
Immune response to recombinant adenovirus in humans: capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes. J Virol (2000) 1.17
Specific recognition of androgens by their nuclear receptor. A structure-function study. J Biol Chem (2000) 1.16
Molecular determinants of adenovirus serotype 5 fibre binding to its cellular receptor CAR. J Gen Virol (1999) 1.16
Host range temperature-conditional mutants in the adenovirus DNA binding protein are defective in the assembly of infectious virus. Virology (1983) 1.16
Variegated gene expression in mice. Trends Genet (1997) 1.15
Transformation by adenovirus early region 2A temperature-sensitive mutants and their revertants. Virology (1981) 1.13
Replication-defective bovine adenovirus type 3 as an expression vector. J Virol (1999) 1.12
Influence of adenoviral fiber mutations on viral encapsidation, infectivity and in vivo tropism. Gene Ther (2001) 1.11
Detection of anti-Epstein-Barr-virus transactivator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma. Int J Cancer (1991) 1.11
Mitochondrial DNA haplogroups and mutations in children with acquired central demyelination. Neurology (2011) 1.10
RU 38486: a potent antiglucocorticoid in vitro and in vivo. J Steroid Biochem (1985) 1.07
The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines. Vaccine (2001) 1.07
Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1. AIDS Res Hum Retroviruses (1997) 1.07
Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response. Immunol Lett (1997) 1.04
Human immunodeficiency virus type 1 infection of human CD4-transgenic rabbits. J Gen Virol (1995) 1.03
Affinity chromatography: large-scale purification of the soluble oestradiol-17- dehydrogenase of human placenta. FEBS Lett (1972) 1.01
Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR. J Med Virol (2001) 1.01
Reporter cell lines to study the estrogenic effects of xenoestrogens. Sci Total Environ (1999) 1.00
Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene products. Hum Gene Ther (2000) 1.00
Mutant carrying deletions in the two simian virus 40 early genes. J Virol (1981) 1.00
Breast cancer protein PS2 synthesis in mammary gland of transgenic mice and secretion into milk. Mol Endocrinol (1989) 1.00
Study of mother-to-child Epstein-Barr virus transmission by means of nested PCRs. J Virol (1996) 0.99
Internalization of alpha 2 macroglobulin in receptosomes. Studies with monovalent electron microscopic markers. Exp Cell Res (1981) 0.99
Structure and function of DNA binding proteins from revertants of adenovirus type 5 mutants with a temperature-sensitive DNA replication. Virology (1983) 0.98
Characterization of the interaction between androgen receptor and a new transcriptional inhibitor, SHP. Biochemistry (2001) 0.97
Study of genetic reassortment between two human rotaviruses. Virology (1984) 0.97
Involvement of the SREBP pathway in the mode of action of androgens in sebaceous glands in vivo. Exp Dermatol (2003) 0.96
Characterization of a plasmid coding for resistance to broad-spectrum cephalosporins in Salmonella typhimurium. Drugs Exp Clin Res (1989) 0.96
Reporter cell lines are useful tools for monitoring biological activity of nuclear receptor ligands. Luminescence (2001) 0.95
Survey of human rotavirus propagation as studied by electrophoresis of genomic RNA. J Infect Dis (1984) 0.95
Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors. Gene Ther (1996) 0.95
Development of a direct in situ RT-PCR method using labeled primers to detect cytokine mRNA inside cells. J Immunol Methods (1999) 0.94
Epidemiologic and genomic study of rotavirus strains infecting young children and calves in the same rural environment. Eur J Epidemiol (1986) 0.94
Serological characterization of human reassortant rotaviruses. J Virol (1986) 0.94
Localization of viral protein X in simian immunodeficiency virus macaque strain and analysis of its packaging requirements. J Gen Virol (1994) 0.93
Analysis of the spontaneous in vitro anti-HIV-1 antibody secretion by peripheral blood mononuclear cells in HIV-1 infection. Clin Exp Immunol (1991) 0.93
Detection of human Betaherpesvirinae in saliva and urine from immunocompromised and immunocompetent subjects. J Clin Microbiol (1997) 0.92
Antibody response to the rubella virus structural proteins in infants with the congenital rubella syndrome. J Med Virol (1986) 0.90
Molecular changes associated with the agonist activity of hydroxy-tamoxifen and the hyper-response to estradiol in hydroxy-tamoxifen-resistant breast cancer cell lines. Endocr Relat Cancer (2005) 0.90
Precocious mammary gland development and milk protein synthesis in transgenic mice ubiquitously expressing human growth hormone. Endocrinology (1991) 0.90
Cytomegalovirus-specific B cell activation as a potential marker for the diagnosis of cytomegalovirus infection. Eur J Clin Microbiol Infect Dis (1990) 0.90
MVLN cells: a bioluminescent MCE-7-derived cell line to study the modulation of estrogenic activity. J Steroid Biochem Mol Biol (1993) 0.90
Antiestrogenic effects of all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms. Cancer Res (1994) 0.90
Porcine adenovirus-3 as a helper-dependent expression vector. J Gen Virol (1999) 0.90
Gene transfer of anti-gp41 antibody and CD4 immunoadhesin strongly reduces the HIV-1 load in humanized severe combined immunodeficient mice. AIDS (2000) 0.89
Conservation of structural domains and biochemical activities of the MDM2 protein from Xenopus laevis. Oncogene (1997) 0.89
Induced expression of B7-1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells. J Immunol (1999) 0.89
Mutation of isoleucine 747 by a threonine alters the ligand responsiveness of the human glucocorticoid receptor. Mol Endocrinol (1996) 0.89
Inhibition of costimulation allows for repeated systemic administration of adenoviral vector in rhesus monkeys. Gene Ther (2004) 0.89
Disorders linked to insufficient androgen action in male children. Hum Reprod Update (2001) 0.87
Construction and characterization of E3-deleted bovine adenovirus type 3 expressing full-length and truncated form of bovine herpesvirus type 1 glycoprotein gD. Virology (1998) 0.87
Regulation of adenovirus-mediated transgene expression by the viral E4 gene products: requirement for E4 ORF3. J Virol (1999) 0.87
Prolonged treatment of breast cancer cells with antiestrogens increases the activating protein-1-mediated response: involvement of the estrogen receptor. Endocrinology (1995) 0.87
Cyclic AMP-dependent phosphorylation in intact cells and in cell-free extracts from Chinese hamster ovary cells. Studies with wild type and cyclic AMP-resistant mutants. J Biol Chem (1981) 0.87
Deletion of the fiber gene induces the storage of hexon and penton base proteins in PML/Sp100-containing inclusions during adenovirus infection. Biol Cell (1999) 0.86
Engineered cell lines as a tool for monitoring biological activity of hormone analogs. Anal Biochem (1997) 0.86
In vivo hepatocyte retrovirus-mediated gene transfer through the rat biliary tract. Hum Gene Ther (1999) 0.86
A mutation in the adenovirus type 5 DNA binding protein that fails to autoregulate the production of the DNA binding protein. Virology (1982) 0.86
Estrogenic activity of cosmetic components in reporter cell lines: parabens, UV screens, and musks. J Toxicol Environ Health A (2005) 0.86
Detection of anti-Epstein-Barr virus trans-activator (ZEBRA) antibodies in sera from patients with human immunodeficiency virus. J Infect Dis (1991) 0.86
Definition and diagnosis of cytomegalovirus colitis in patients infected by human immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.86
Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling. Cancer Res (2000) 0.85
Effect of ubiquitin on platelet functions: possible identity with platelet activity suppressive lymphokine (PASL). Eur J Immunol (1991) 0.85
Some new developments in the knowledge of human placental estradiol-17beta dehydrogenase. J Steroid Biochem (1977) 0.85
Treatment interruption after one year of triple nucleoside analogue therapy for primary HIV infection. AIDS (2001) 0.85